Innovative Biomarkers for Diagnosing Malignant Ascites in Liver Cancer
The combined evaluation of HF-BF%, Ratio2, and NSE serves as a valuable indicator for predicting the occurrence of metastatic malignant ascites in liver cancer patients.
Authors
- Huaizhong Cui
- Aifang Xu (ORCID: https://orcid.org/0000-0002-1059-3116)
- Lingyan He
- Yan Zhang (ORCID: https://orcid.org/0000-0003-2211-8539)
- Kaichun Wu (ORCID: https://orcid.org/0000-0002-0699-9666)
- Kailong Gu
- Xiaojing Zhang (ORCID: https://orcid.org/0000-0002-4964-0960)
Institutions
- Hangzhou Xixi hospital (CN)
Publication Details
- Journal
- OncoTargets and Therapy
- Published
- 2025-08-01
- DOI
- https://doi.org/10.2147/ott.s527224
- Citations
- 1
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.35